Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2025-12-26 @ 1:49 AM
Study NCT ID:
NCT01158105
Status:
UNKNOWN
Last Update Posted:
2016-01-18
First Post:
2010-07-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)
Sponsor:
Baylor Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
010-037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |